The Key to improved cancer therapy.
the Annual General Meeting of Clavis Pharma ASA was held on 17 June 2013. Please find the minutes of the Annual General Meeting attached
Reference is made to the announcement of 24 May 2013 regarding Clavis Pharma ASA's Annual General Meeting 2013, and agenda item 6 and 8: Remuneration for the Board of Directors and Election of Board members.
Please follow the link below to VPS for electronical registration to attend the Extraordinary General Meeting on 17 June 2013 at 14:00 hours at Parkveien 53B, Oslo. The link will be activated on Monday 27 May.
Martin Nes, a board member of the Company, as Interim Chairman of the Board of Directors and Gunnar Manum, the CFO of Clavis Pharma, to the additional position of Acting CEO